AS A result of the widespread use of dicumarol in the prevention and treatment of thromboembolism, clinicians have become increasingly interested in the role of prothrombin in blood coagulation.
THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback